The global ulcerative colitis market is forecast to grow at a CAGR of 6.6% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global ulcerative colitis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used to treat ulcerative colitis.
The report, Global Ulcerative Colitis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the strengths and weaknesses of the key vendors?
Companies Mentioned Include:
- Janssen Biotech
- Takeda Pharmaceuticals
- Ajinomoto Pharmaceuticals
- Arena Pharmaceuticals
- Astellas Pharma
- Avaxia Biologics
- Cosmo Pharmaceuticals
- Kissei Pharmaceutical
- Kyowa Hakko Kirin
- Lipid Therapeutics
- Shield Therapeutics
- Shire Pharmaceuticals
- Sterna Biologicals
- Tillotts Pharma
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Disease overview
PART 06: Pipeline analysis
PART 07: Market landscape
PART 08: Market segmentation by molecule type
PART 09: Market segmentation by dosage form
PART 10: Market segmentation by route of administration
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Appendix
PART 19: About the Author
For more information visit http://www.researchandmarkets.com/research/hlfghc/global_ulcerative